Therapeutic index of methotrexate depends on circadian cycling of tumour necrosis factor-α in collagen-induced arthritic rats and mice

Journal of Pharmacy and Pharmacology

Volumn 61, Issue 10, 2009, Pages 1333-1338

  To, Hideto ^a   Irie, Sadaharu ^a   Tomonari, Mari ^a   Watanabe, Yuko ^a   Kitahara, Takashi ^a  

^a NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

24 h rhythm; Methotrexate; Rheumatoid arthritis; Tumour necrosis factor

Indexed keywords

COLLAGEN; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA; ANTIRHEUMATIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BLOOD SAMPLING; CIRCADIAN RHYTHM; CONTROLLED STUDY; DARK ADAPTATION; DOSE RESPONSE; DRUG ABSORPTION; IMMUNIZATION; LEUKOCYTE COUNT; LIGHT ADAPTATION; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; SINGLE DRUG DOSE; ANIMAL; BLOOD; DBA MOUSE; DRUG ADMINISTRATION; LEWIS RAT; TIME;

ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; CIRCADIAN RHYTHM; DRUG ADMINISTRATION SCHEDULE; LEUKOCYTE COUNT; METHOTREXATE; MICE; MICE, INBRED DBA; RATS; RATS, INBRED LEW; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85047681201     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.61.10.0009     Document Type: Article

References (32)

1. Tabuchi M et al. Therapeutic index by combination of adriamycin and docetaxel depends on dosing time in mice. Cancer Res 2005; 65: 8448-8454.
2. Ushijima K et al. Chronopharmacological study of antidepressants in forced swimming test of mice. J Pharmacol Exp Ther 2005; 315: 764-770.
3. Iurisci I et al. Improved tumor control through circadian clock induction by Seliciclib, a cyclin-dependent kinase inhibitor. Cancer Res 2006; 66: 10720-10728.
4. Tampellini M et al. Docetaxel chronopharmacology in mice. Cancer Res 1998; 58: 3896-3904.
5. Matsunaga N et al. Influence of feeding schedule on 24-h rhythm of hepatotoxicity induced by acetaminophen in mice. J Pharmacol Exp Ther 2004; 311: 594-600.
6. Koyanagi S et al. Glucocorticoid regulation of 24-hour oscillation in interferon receptor gene expression in mouse liver. Endocrinology 2006; 147: 5034-5040.
7. Saito Y et al. Comparison between morning and evening doses of simvastatin in hyperlipidemic subjects. A double-blind comparative study. Arterioscler Thromb 1991; 11: 816-826.
8. D'Alonzo GE et al. Bambuterol in the treatment of asthma. A placebo-controlled comparison of once-daily morning vs evening administration. Chest 1995; 107: 406-412.
9. Harris ED. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990; 322: 1277-1289.
10. Gabriel SE. The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 2001; 27: 269-281.
11. Arnett FC et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
12. Kowanko IC et al. Domiciliary self-measurement in the rheumatoid arthritis and the demonstration of circadian rhythmicity. Ann Rheum Dis 1982; 41: 453-455.
13. Harkness JA et al. Circadian variation in disease activity in rheumatoid arthritis. Br Med J 1982; 284: 551-554.
14. Bellamy N et al. Circadian rhythm in pain, stiffness, and manual dexterity in rheumatoid arthritis: relation between discomfort and disability. Ann Rheum Dis 1991; 50: 243-248.
15. Arvidson NG et al. The timing of glucocorticoid administration in rheumatoid arthritis. Ann Rheum Dis 1997; 56: 27-31.
16. Sulli A et al. Melatonin serum levels in rheumatoid arthritis. Ann NY Acad Sci 2002; 966: 276-283.
17. Lightfoot RW. Benoxaprofen administered once a day: determination of optimum dosage schedule. J Rheum 1980; 6: 61-67.
18. Arvidson NG et al. Circadian rhythm of serum interleukin-6 in rheumatoid arthritis. Ann Rheum Dis 1994; 53: 521-524.
19. Buttgereit F et al. Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial. Lancet 2008; 371: 205-214.
20. Ohdo S et al. Chronotoxicity of methotrexate in mice and its relation to circadian rhythm of DNA synthesis and pharmacokinetics. Jpn J Pharmacol 1997; 75: 283-290.
21. Meng HC et al. Identification of two novel female-specific nonmajor histocompatibility complex loci regulating collageninduced arthritis severity and chronicity, and evidence of epistasis. Arthritis Rheum 2004; 50: 2695-2705.
22. Nandakumar KS et al. Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex and genes. Am J Pathol 2003; 163: 1827-1837.
23. Wooley PH et al. Type II collagen-induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of anti-type II collagen antibody or free native type II collagen. Arthritis Rheum 1984; 27: 1010-1017.
24. Holmdahl R et al. Collagen induced arthritis as an experimental model for rheumatoid arthritis. Immunogenetics, pathogenesis and autoimmunity. APMIS 1989; 97: 575-584.
25. Cuzzocrea S et al. Synergistic interaction between methotrexate and a superoxide dismutase mimetic: pharmacologic and potential clinical significance. Arthritis Rheum 2005; 52: 3755-3760.
26. Labrecque G et al. 24-hour variations in the distribution of labeled microspheres to the intestine, liver and kidneys. Annu Rev Chronopharmacol 1988; 5: 445-448.
27. Cal JC et al. Circadian and circannual changes in nephrotoxic effects of heavy metals and antibiotics. Annu Rev Chronopharmacol 1986; 2: 143-176.
28. Chu CQ et al. Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patientswith rheumatoid arthritis. Arthritis Rheum 1991; 34: 1125-1132.
29. Marinova-Mutafchieva L et al. Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA). Clin Exp Immunol 1997; 107: 507-512.
30. Mussener A et al. Cytokine production in synovial tissue of mice with collagen-induced arthritis (CIA). Clin Exp Immunol 1997; 107: 485-493.
31. Abe C et al. Spontaneous polyarthritis in MRL/l mice. Ryumachi 1980; 20: 233-239.
32. Koopman WJ, Gay S. The MRL-lpr/lpr mouse. A model for the study of rheumatoid arthritis. Scand J Rheumatol 1988; 75: 284-289.